Biomanufacturing: a high-growth industry for North Carolina

Related Experiment Video

Updated: Aug 15, 2026

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
06:18

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on: August 18, 2023

Boris Hartl1

  • 1North Carolina Biotechnology Center, 15 T.W. Alexander Drive, Post Office Box 13547, Research Triangle Park, NC 27709-3547, USA. boris_hartl@ncbiotech.org

Drug Discovery Today
|November 1, 2005
PubMed

Abstract:

The sustained growth of biotechnology in North Carolina has made the state a worldwide leader in biotechnology.

More Related Videos

Synthesis of Keratin-based Nanofiber for Biomedical Engineering
14:43

Synthesis of Keratin-based Nanofiber for Biomedical Engineering

Published on: February 7, 2016

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Related Experiment Videos

Last Updated: Aug 15, 2026

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
06:18

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on: August 18, 2023

Synthesis of Keratin-based Nanofiber for Biomedical Engineering
14:43

Synthesis of Keratin-based Nanofiber for Biomedical Engineering

Published on: February 7, 2016

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Related Concept Videos

Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Designing Growth Media for Bioreactors01:30

Designing Growth Media for Bioreactors

Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...

Articles linked to this work by shared authors, journal, and citation graph.

Programmable STING-activating hydrogels for in situ cancer vaccination: Spatiotemporal design and mechanistic evidence.

Drug discovery today·2026

Everything is local: a framework for clinical global assessment in drug development.

Drug discovery today·2026

Target-state uncertainty in drug discovery: when precise binding data describe the wrong system.

Drug discovery today·2026

The Activity Wall in Alzheimer's drug discovery: When potency optimization reaches its limits.

Drug discovery today·2026

UHRF1-mediated epigenetic dysregulation in tumors: Mechanisms, therapeutic resistance and targeted inhibitors.

Drug discovery today·2026

Crosstalk between the cell cycle and ferroptosis in tumor cells.

Drug discovery today·2026

Nurses' bioterrorism preparedness: an evolutionary concept analysis.

Frontiers in public health·2026

Complete genome sequence of Bacillus licheniformis strain Ukraine01 isolated from bovine biomaterial in Ukraine.

Microbiology resource announcements·2026

Invisible Infrastructure at Risk: Funding Crises Threaten Global Bioscience Research.

Genetics·2026

From cells to sales: Advancing the commercialization of industrial biotech innovations.

New biotechnology·2026

A NanoBiT-based high-throughput assay system for monitoring osteoclast fusion.

Analytical biochemistry·2026

Thailand's Synthetic Biology Strategy.

Engineering biology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us